The Management of Hypertension in Pregnancy

Andrea G. Kattah; Vesna D. Garovic

doi:10.1053/j.ackd.2013.01.014

The Management of Hypertension in Pregnancy

Andrea G. Kattah, Vesna D. Garovic

Nephrology and Hypertension

Research output: Contribution to journal › Review article › peer-review

58 Scopus citations

Abstract

Hypertensive pregnancy disorders complicate 6% to 8% of pregnancies and cause significant maternal and fetal morbidity and mortality. The goal of treatment is to prevent significant cerebrovascular and cardiovascular events in the mother without compromising fetal well-being. Current guidelines differentiate between the treatment of women with acute hypertensive syndromes of pregnancy and women with preexisting chronic hypertension in pregnancy. This review will address the management of hypertension in pregnancy, review the various pharmacologic therapies, and discuss the future directions in this field.

Original language	English (US)
Pages (from-to)	229-239
Number of pages	11
Journal	Advances in Chronic Kidney Disease
Volume	20
Issue number	3
DOIs	https://doi.org/10.1053/j.ackd.2013.01.014
State	Published - May 2013

Keywords

Antihypertensive agents
Gestational hypertension
Hypertension
Preeclampsia
Pregnancy

ASJC Scopus subject areas

Nephrology

Access to Document

10.1053/j.ackd.2013.01.014

Cite this

@article{846ef0954c194606a2533880f38323ff,

title = "The Management of Hypertension in Pregnancy",

abstract = "Hypertensive pregnancy disorders complicate 6% to 8% of pregnancies and cause significant maternal and fetal morbidity and mortality. The goal of treatment is to prevent significant cerebrovascular and cardiovascular events in the mother without compromising fetal well-being. Current guidelines differentiate between the treatment of women with acute hypertensive syndromes of pregnancy and women with preexisting chronic hypertension in pregnancy. This review will address the management of hypertension in pregnancy, review the various pharmacologic therapies, and discuss the future directions in this field.",

keywords = "Antihypertensive agents, Gestational hypertension, Hypertension, Preeclampsia, Pregnancy",

author = "Kattah, {Andrea G.} and Garovic, {Vesna D.}",

note = "Funding Information: The project described was supported by Award Number K08 HD051714 (Vesna D. Garovic) from the Eunice Kennedy Shriver National Institute of Child Health & Human Development and by Award Number P-50 AG44170 (V.D.G.) from the National Institute on Aging . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The writing of the manuscript and the decision to submit it for publication were solely the authors' responsibilities. ",

year = "2013",

month = may,

doi = "10.1053/j.ackd.2013.01.014",

language = "English (US)",

volume = "20",

pages = "229--239",

journal = "Advances in Chronic Kidney Disease",

issn = "1548-5595",

publisher = "W.B. Saunders Ltd",

number = "3",

}

TY - JOUR

T1 - The Management of Hypertension in Pregnancy

AU - Kattah, Andrea G.

AU - Garovic, Vesna D.

N1 - Funding Information: The project described was supported by Award Number K08 HD051714 (Vesna D. Garovic) from the Eunice Kennedy Shriver National Institute of Child Health & Human Development and by Award Number P-50 AG44170 (V.D.G.) from the National Institute on Aging . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The writing of the manuscript and the decision to submit it for publication were solely the authors' responsibilities.

PY - 2013/5

Y1 - 2013/5

N2 - Hypertensive pregnancy disorders complicate 6% to 8% of pregnancies and cause significant maternal and fetal morbidity and mortality. The goal of treatment is to prevent significant cerebrovascular and cardiovascular events in the mother without compromising fetal well-being. Current guidelines differentiate between the treatment of women with acute hypertensive syndromes of pregnancy and women with preexisting chronic hypertension in pregnancy. This review will address the management of hypertension in pregnancy, review the various pharmacologic therapies, and discuss the future directions in this field.

AB - Hypertensive pregnancy disorders complicate 6% to 8% of pregnancies and cause significant maternal and fetal morbidity and mortality. The goal of treatment is to prevent significant cerebrovascular and cardiovascular events in the mother without compromising fetal well-being. Current guidelines differentiate between the treatment of women with acute hypertensive syndromes of pregnancy and women with preexisting chronic hypertension in pregnancy. This review will address the management of hypertension in pregnancy, review the various pharmacologic therapies, and discuss the future directions in this field.

KW - Antihypertensive agents

KW - Gestational hypertension

KW - Hypertension

KW - Preeclampsia

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=84876858912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876858912&partnerID=8YFLogxK

U2 - 10.1053/j.ackd.2013.01.014

DO - 10.1053/j.ackd.2013.01.014

M3 - Review article

C2 - 23928387

AN - SCOPUS:84876858912

SN - 1548-5595

VL - 20

SP - 229

EP - 239

JO - Advances in Chronic Kidney Disease

JF - Advances in Chronic Kidney Disease

IS - 3

ER -

The Management of Hypertension in Pregnancy

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this